Aligos Therapeutics, Inc. (ALGS)
6.80
-0.32
(-4.49%)
USD |
NASDAQ |
Feb 20, 16:00
6.91
+0.11
(+1.62%)
After-Hours: 20:00
Aligos Therapeutics SG&A Expense (Quarterly) : 5.165M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Johnson & Johnson | 6.753B |
| ACADIA Pharmaceuticals, Inc. | 133.40M |
| Agenus, Inc. | 10.86M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| Savara, Inc. | 9.627M |